Alliancebernstein L.P. Pliant Therapeutics, Inc. Transaction History
Alliancebernstein L.P.
- $278 Billion
- Q2 2024
A detailed history of Alliancebernstein L.P. transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 59,080 shares of PLRX stock, worth $668,194. This represents 0.0% of its overall portfolio holdings.
Number of Shares
59,080
Previous 59,080
-0.0%
Holding current value
$668,194
Previous $880,000
27.84%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding PLRX
# of Institutions
158Shares Held
63.8MCall Options Held
481KPut Options Held
105K-
Deep Track Capital, LP Greenwich, CT5.97MShares$67.5 Million2.11% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$56.2 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.6MShares$52.1 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.44MShares$38.9 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN3.4MShares$38.5 Million3.33% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $551M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...